Surface Oncology
Surface Oncology is a Massachusetts-based clinical-stage immuno-oncology company that researches and develops antibody therapies for the treatment of cancer.
Business Model:
Revenue: $32.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Surface Oncology Information
Surface Oncology was acquired by
Coherus Biosciences.
The acquisition happend on 2023-06-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 50 Hampshire Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$29M
Raised Total:$89M
Social
Metrics
3,626,944Website Global Rank
3,703Website Monthly Traffic
Twitter Followers
Description
Surface Oncology is a Massachusetts-based clinical-stage immuno-oncology company that researches and develops antibody therapies for the treatment of cancer.
Contact Phone:
+16177144096
Contact Email:
Surface Oncology went public on 4/19/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/19/2018
Ticker Symbol:
SURF
IPO Price:
$15/share
Amount Raised:
$120M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2014 | Seed | - | 5/2020 | Post-IPO Equity | 4 | $28.9M |
RS Investments Venrock Healthcare Capital Partners Biotechnology Value Fund EcoR1 Capital RS Investments Venrock Healthcare Capital Partners Biotechnology Value Fund EcoR1 Capital |
11/2019 | Debt Financing | 1 | $25M |
K2 HealthVentures K2 HealthVentures K2 HealthVentures |
9/2014 | Seed Round | 2 | - |
Eight Roads Ventures Atlas Venture Eight Roads Ventures Atlas Venture |
4/2018 | Private Placement | $11.5M | 11/2019 | Debt | $7.5M |
K2 HealthVentures |
4/2018 | IPO | $108M | 1/2015 | Series A | 7 | $35M |
New Enterprise Associates Lilly Ventures Amgen Ventures Novartis Institutes for Biomedical Research Atlas Venture Elliott Sigal Atlas Venture F-Prime Capital New Enterprise Associates Lilly Ventures Amgen Ventures Novartis Institutes for Biomedical Research Atlas Venture Atlas Venture |
12/2014 | Seed | - |
Atlas Venture Atlas Venture |
9/2014 | Seed Round | 2 | - |
Eight Roads Ventures Eight Roads Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
